As of November 6, 2026, Nexalin Technology, Inc. is a publicly traded company (Nasdaq: NXL). The largest holder reporting an active stake on Schedule 13D is Greenlight Ventures, LLC, at 5.6%. No bankruptcy or receivership appears in its SEC Form 8-K filings. Passive holders reporting on Schedule 13G include Alumni Capital LP (9.99%) (Schedule 13D, September 3, 2026).
Is this your company?
About to sign with, pay or invest in Nexalin Technology, Inc.? See the free Snapshot first.
Free to see. No signup.
Is Nexalin Technology, Inc. a real, registered company?
- Nexalin Technology, Inc. files with the SEC under CIK 1527352 (its SEC filings).
- Its shares are listed under the ticker NXL on Nasdaq (SEC company record).
- Incorporated in Delaware; business address in Houston, Texas, as its SEC filings state.
- Court and bankruptcy records: see Before you sign or pay below.
Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under Nexalin Technology, Inc. in our court records and SEC 8-K records (as of 2026-11-06).
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names Greenlight Ventures, LLC (filed 2026-09-03).
Who are Nexalin Technology, Inc.'s owners and officers?
Nexalin Technology, Inc.: incorporated in Delaware; business address in Houston, Texas; industry Electromedical & Electrotherapeutic Apparatus (S-1/A, 2026-10-08).
| Report | Holder | Share |
|---|---|---|
| Schedule 13D, 2026-09-03 | Greenlight Ventures, LLC | 5.6% |
| Schedule 13G, 2026-08-27 | Alumni Capital LP | 9.99% |
Questions about who owns Nexalin Technology, Inc.
Who owns Nexalin Technology, Inc.?
On this page, 2 holders' latest ownership filings report 5% or more of Nexalin Technology, Inc.: Alumni Capital LP (9.99%, Schedule 13G, filed 2026-08-27) and Greenlight Ventures, LLC (5.6%, Schedule 13D, filed 2026-09-03).
Who are the largest shareholders of Nexalin Technology, Inc.?
By the share each holder's latest filing reports, the largest holders of Nexalin Technology, Inc. on this page are Alumni Capital LP (9.99%) and Greenlight Ventures, LLC (5.6%).
When did Alumni Capital LP buy into Nexalin Technology, Inc.?
The filings give report dates, not purchase dates. The earliest filing from Alumni Capital LP on this page is the Schedule 13G, filed 2026-08-27, reporting 9.99%.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 2 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Want the whole picture on Nexalin Technology, Inc.?
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Nexalin Technology, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Nexalin Technology, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
12 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Which insiders own Nexalin Technology, Inc. shares?
Directors, officers and holders of 10% or more report their shares on Forms 3, 4 and 5. Each line is the latest such report, largest holding first.
- , a 10% owner: 1,618,577 shares (7.3% of shares outstanding), on a joint filing (Form 4, 2025-09-30).
- Marilyn Elson: 1,618,577 shares (7.3% of shares outstanding), on a joint filing (Form 4, 2025-09-30).
- , a director: 377,095 shares (1.7% of shares outstanding) (Form 4, 2025-09-30).
- , the chief medical officer and a director: 191,252 shares (0.87% of shares outstanding) (Form 4, 2025-09-30).
- , a director: 119,590 shares (0.54% of shares outstanding), held indirectly through an owned by alan and natalie kazden family trust (Form 4, 2025-09-30).
Shares outstanding: 22,036,402 as of 2026-08-10, from the company's latest SEC cover page.
How much has Nexalin Technology, Inc. raised?
Latest IPO step: Nexalin Technology, Inc. amended its IPO registration (S-1/A, 2026-10-08).
IPO filings: S-1/A, 2026-10-08, S-1, 2026-09-03, 424B4, 2025-05-06, 424B4, 2025-05-02, S-1/A, 2025-01-30; ticker NXL on Nasdaq Capital Market.
Keep reading
More on Nexalin Technology, Inc. and the records around it.
Nexalin Technology, Inc. elsewhere on the record
- 5%+ stake filings Sep 2026
Companies that share a holder
- Alumni Capital LP also filed stake reports on 12 other companies: reAlpha Tech Corp. (Nov 2026), Sports Entertainment Gaming Global Corp (Nov 2026), INVO Fertility, Inc. (Aug 2026)
Related pages
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
https://mentionfox.com/who-owns/nexalin-technology